Cargando…

miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer

miRNAs are 20–22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kousar, Kousain, Ahmad, Tahir, Abduh, Maisa S., Kanwal, Balquees, Shah, Syeda Saba, Naseer, Faiza, Anjum, Sadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699074/
https://www.ncbi.nlm.nih.gov/pubmed/36430305
http://dx.doi.org/10.3390/ijms232213822
_version_ 1784838979642720256
author Kousar, Kousain
Ahmad, Tahir
Abduh, Maisa S.
Kanwal, Balquees
Shah, Syeda Saba
Naseer, Faiza
Anjum, Sadia
author_facet Kousar, Kousain
Ahmad, Tahir
Abduh, Maisa S.
Kanwal, Balquees
Shah, Syeda Saba
Naseer, Faiza
Anjum, Sadia
author_sort Kousar, Kousain
collection PubMed
description miRNAs are 20–22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these two hallmarks by desensitizing important tumor-sensitive regulatory cells such as dendritic cells, M1 macrophages, and T helper cells towards tumors while supporting infiltration and proliferation of immune cells like Treg cells, tumor-associated M2 macrophages that promote self-tolerance and chronic inflammation. miRNAs have a significant role in enhancing the efficacies of immunotherapy treatments like checkpoint blockade therapy, adoptive T cell therapy, and oncolytic virotherapy in cancer. A clear understanding of the role of miRNA can help scientists to formulate better-targeted treatment modalities. miRNA therapeutics have emerged as diverse class of nucleic acid-based molecules that can suppress oncogenic miRNAs and promote the expression of tumor suppressor miRNAs.
format Online
Article
Text
id pubmed-9699074
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96990742022-11-26 miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer Kousar, Kousain Ahmad, Tahir Abduh, Maisa S. Kanwal, Balquees Shah, Syeda Saba Naseer, Faiza Anjum, Sadia Int J Mol Sci Review miRNAs are 20–22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these two hallmarks by desensitizing important tumor-sensitive regulatory cells such as dendritic cells, M1 macrophages, and T helper cells towards tumors while supporting infiltration and proliferation of immune cells like Treg cells, tumor-associated M2 macrophages that promote self-tolerance and chronic inflammation. miRNAs have a significant role in enhancing the efficacies of immunotherapy treatments like checkpoint blockade therapy, adoptive T cell therapy, and oncolytic virotherapy in cancer. A clear understanding of the role of miRNA can help scientists to formulate better-targeted treatment modalities. miRNA therapeutics have emerged as diverse class of nucleic acid-based molecules that can suppress oncogenic miRNAs and promote the expression of tumor suppressor miRNAs. MDPI 2022-11-10 /pmc/articles/PMC9699074/ /pubmed/36430305 http://dx.doi.org/10.3390/ijms232213822 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kousar, Kousain
Ahmad, Tahir
Abduh, Maisa S.
Kanwal, Balquees
Shah, Syeda Saba
Naseer, Faiza
Anjum, Sadia
miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
title miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
title_full miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
title_fullStr miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
title_full_unstemmed miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
title_short miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
title_sort mirnas in regulation of tumor microenvironment, chemotherapy resistance, immunotherapy modulation and mirna therapeutics in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699074/
https://www.ncbi.nlm.nih.gov/pubmed/36430305
http://dx.doi.org/10.3390/ijms232213822
work_keys_str_mv AT kousarkousain mirnasinregulationoftumormicroenvironmentchemotherapyresistanceimmunotherapymodulationandmirnatherapeuticsincancer
AT ahmadtahir mirnasinregulationoftumormicroenvironmentchemotherapyresistanceimmunotherapymodulationandmirnatherapeuticsincancer
AT abduhmaisas mirnasinregulationoftumormicroenvironmentchemotherapyresistanceimmunotherapymodulationandmirnatherapeuticsincancer
AT kanwalbalquees mirnasinregulationoftumormicroenvironmentchemotherapyresistanceimmunotherapymodulationandmirnatherapeuticsincancer
AT shahsyedasaba mirnasinregulationoftumormicroenvironmentchemotherapyresistanceimmunotherapymodulationandmirnatherapeuticsincancer
AT naseerfaiza mirnasinregulationoftumormicroenvironmentchemotherapyresistanceimmunotherapymodulationandmirnatherapeuticsincancer
AT anjumsadia mirnasinregulationoftumormicroenvironmentchemotherapyresistanceimmunotherapymodulationandmirnatherapeuticsincancer